1. Consistent Osteoblastic Differentiation of Human Mesenchymal Stem Cells with Bone Morphogenetic Protein 4 and Low Serum
- Author
-
Luc Sensebé, Frédéric Deschaseaux, Pierre Layrolle, Alain Langonné, Jérôme Sohier, Philippe Rosset, Thomas Cordonnier, Micro et Nanomédecines Biomimétiques, Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Theraptosis Research Laboratory, Theraptosis S.A., Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM), Equipe de recherche clinique en Odontologie (ERT1051), Université de Nantes (UN), Sarcomes osseux et remodelage des tissus calcifiés - Phy-Os [Nantes] (INSERM U1238), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Bretagne Loire (UBL)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Etablissement Français du Sang Centre-Atlantique (EA3855), EFS, Micro et Nanomédecines Biomimétiques (MINT), Physiopathologie des Adaptations Nutritionnelles (PhAN), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Sarcomes osseux et remodelage des tissus calcifiés - Phy-Os [Nantes - INSERM U1238] (Phy-Os), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), and Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université Bretagne Loire (UBL)
- Subjects
Adult ,Serum ,Ceramics ,Biomedical Engineering ,Medicine (miscellaneous) ,Bioengineering ,Bone Morphogenetic Protein 4 ,Bone morphogenetic protein ,Regenerative medicine ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Osteogenesis ,medicine ,Animals ,Humans ,[SDV.IB.BIO]Life Sciences [q-bio]/Bioengineering/Biomaterials ,ComputingMilieux_MISCELLANEOUS ,030304 developmental biology ,Aged ,Cell Proliferation ,Aged, 80 and over ,0303 health sciences ,Osteoblasts ,Tissue Scaffolds ,Chemistry ,Gene Expression Profiling ,Mesenchymal stem cell ,Cell Differentiation ,Mesenchymal Stem Cells ,Middle Aged ,Alkaline Phosphatase ,Flow Cytometry ,In vitro ,3. Good health ,Cell biology ,Bone morphogenetic protein 7 ,Bone morphogenetic protein 6 ,medicine.anatomical_structure ,Bone morphogenetic protein 4 ,Gene Expression Regulation ,030220 oncology & carcinogenesis ,Immunology ,Bone marrow - Abstract
Providing fully mature and functional osteoblasts is challenging for bone tissue engineering and regenerative medicine. Such cells could be obtained from multipotent bone marrow mesenchymal stem cells (MSCs) after induction by different osteogenic factors. However, there are some discrepancies in results, notably due to the use of sera and to the type of osteogenic factor. In this study, we compared the osteogenic differentiation of bone marrow MSCs induced by dexamethasone (Dex) or bone morphogenetic proteins (BMPs) by assessing phenotypes in vitro and functional osteoblasts in vivo. Reducing the content of fetal calf serum from 10% to 2% significantly increased the mineral deposition and expression of osteoblastic markers during osteogenesis. In comparison to Dex condition, the addition of BMP4 greatly improved the differentiation of MSCs into fully mature osteoblasts as seen by high expression of Osterix. These results were confirmed in different supportive matrixes, plastic flasks, or biphasic calcium phosphate biomaterials. In contrast to Dex-derived osteoblasts, BMP4-derived osteoblasts from MSCs were significantly able to produce new bone in subcutis of nude mice in accordance with in vitro results. In conclusion, we describe a convenient ex vivo method to produce consistently mature functional osteoblasts from human MSCs with use of BMP4 and low serum.
- Published
- 2011
- Full Text
- View/download PDF